Bio-equivalent tests to be mandatory.

Published: 2001-12-18 06:59:00

Updated: 2001-12-18 06:59:00

The KFDA plans for the bio-equivalent test gradually to be mandatory in process of the drug health registration in order to activate the test. Furthermore, the KFDA intends to recommend an incentive plan to the MOHW for the drugs completed with the test including discriminated NHI reimbursement.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK